Development of Glypican 3–Targeting Antibody–Drug Conjugates for Hepatocellular Carcinoma Therapy

Cancer Research Communications · Published 2026-06-16 · DOI 10.1158/2767-9764.crc-26-0139

Free full text

Authors (18)

Ning Li, Yu Zeng, Xiaolin Xiong, Peng Zhang, Xiaolun Peng, Wenbin Chen, Wen Wei, Xiaozhen Xia, Ruihong Liu, Yao Lu, Mengyuan Geng, Xianqing Lan, Xiuqi Li, Tingting Yuan, Ying Huang, Ying Xiao, Zongchun Mou, Junming Yie

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Li, N., Zeng, Y., Xiong, X., et al. (2026). Development of Glypican 3–Targeting Antibody–Drug Conjugates for Hepatocellular Carcinoma Therapy. Cancer Research Communications. https://doi.org/10.1158/2767-9764.crc-26-0139

Related articles

• Chemotherapy-Induced Neutropenia in Palestinian Patients with Solid Malignancies: Patient Characteristics, Severity Risk Factors, and Management Patterns · Cancer Research Communications · 2026 · Same journal
• Clinical Validation of Tissue and Liquid Companion Diagnostics for BRAF V600E Detection in Non–Small Cell Lung Cancers from the PHAROS Study · Cancer Research Communications · 2026 · Same journal
• Acquisition of Resistance to RAS Inhibition Is Associated with the Upregulation of Macropinocytosis through Both PI3K-Dependent and -Independent Signaling · Cancer Research Communications · 2026 · Same journal
• Transcriptionally Informed Nucleosome Profiling of Circulating Cell-Free DNA Predicts Breast Cancer Recurrence · Cancer Research Communications · 2026 · Same journal
• Tumor-Associated Platelets Suppress T-cell Function and Promote Immune Evasion in TNBC via the P-selectin/P-selectin Glycoprotein Ligand 1 Pathway · Cancer Research Communications · 2026 · Same journal
• Natural Autoantibodies Negatively Correlate with Hepatocellular Carcinoma Incidence in Cirrhosis · Cancer Research Communications · 2026 · Same journal
• BRAF Inhibition–Associated Nuclear Remodeling is Linked to Cancer-Associated Fibroblast Activation · Cancer Research Communications · 2026 · Same journal
• Tissue Context Shapes Distinct Premalignant Outcomes in an HPV16 E6/E7-Mutant Pik3ca Transgenic Mouse Model · Cancer Research Communications · 2026 · Same journal
• Glioblastoma subtypes exhibit distinct migration mechanics and immune responses · Cancer Research Communications · 2026 · Same journal
• Interleukin-34–Induced Arg1+ Macrophages Play a Key Role in Breast Cancer Brain Metastasis · Cancer Research Communications · 2026 · Same journal